ReproNovo
Lausanne
About ReproNovo
ReproNovo is providing patients all over the world with significant improvement by developing cutting-edge therapeutic solutions for uterine disorders including adenomyosis and for male and female infertility.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $65.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2025)
- Website: repronovo.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Fertility, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/repronovo-23096 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.